Study of I Line FOLFOX + Panitumumab vs 5FU + Panitumumab in RAS and BRAF WT Metastatic Colorectal Cancer Elderly Patients
Clinical trial NCT02904031 · UNKNOWN
Trial details
- NCT number
- NCT02904031
- Sponsor
- Gruppo Oncologico del Nord-Ovest
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2019-11-15
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.